TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Adherium Ltd. ( (AU:ADR) ) has provided an announcement.
Adherium Limited has issued 19,000,000 fully paid ordinary shares without disclosure to investors under the Corporations Act. The company confirms compliance with relevant provisions and states there is no excluded information to disclose. This move is part of Adherium’s ongoing efforts to enhance its market presence and operational capabilities, potentially impacting its industry positioning and stakeholder interests.
The most recent analyst rating on (AU:ADR) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Adherium Ltd. stock, see the AU:ADR Stock Forecast page.
More about Adherium Ltd.
Adherium is a leader in connected respiratory medical devices, offering integrated digital health solutions through its Hailie® platform. This platform allows clinicians, healthcare providers, and patients to monitor medication usage and adherence remotely, facilitating reimbursement for patient management. The Hailie® solution includes tools for data capture and sharing via apps, SDK, and API integration, along with sensors for respiratory medications, aiding healthcare providers in understanding patient respiratory disease patterns.
Technical Sentiment Signal: Sell
Current Market Cap: A$9.97M
Find detailed analytics on ADR stock on TipRanks’ Stock Analysis page.